is tirzepatide better than semaglutide for weight loss why vs. loss—what's the difference? 🤔Both have Weight loss: Semaglutide or tirzepatide,

And even if you have an excellent diet and exercise plan, you may still struggle to see the results youre looking for

PT-141 is not approved by the U.S

Chris Boshoff, MD, PhD, Chief Scientific Officer and President, Research and Development at Pfizer, commented: Cardiovascular and metabolic diseases including obesity remain important areas of unmet medical need, and we plan to continue applying our global capabilities to advance a pipeline of investigational treatments that have the potential to fill critical gaps in patient care, including continued development of our oral GIPR antagonist candidate and other earlier obesity programmes. Future directions in metabolic disease Despite this setback, Pfizer confirmed its ongoing commitment to metabolic disease research, with particular focus on its oral gastric inhibitory polypeptide receptor (GIPR) antagonist candidate and other earlier-stage obesity programmes

doi:10.1080/10601320500189604

Contact the study site directly or ask your doctor for a referral

Your provider should review your medications, blood pressure history, cardiovascular risk, and overall health